What’s New in Photon Counting CT?

October 12, 2026 · 6 articles · 7 research themes · covering October 05, 2026 – October 12, 2026

Overview

This week’s set of papers and reviews converges on a central theme: photon-counting (PCD/PCCT) and spectral CT are moving from “promising physics” toward quantifiable, protocol-ready clinical tools. Laboratory and imaging studies emphasize that spectral outputs—especially iodine concentration in CT iodine maps—can be characterized using detection/quantification limits and linearity frameworks, enabling more direct system-to-system comparisons. In parallel, clinical translation is being supported by evidence that PCCT can measure biologically relevant tissue composition (e.g., vertebral bone marrow adipose tissue) with measurable agreement to MRI proton density fat fraction (PDFF), suggesting CT may increasingly complement or reduce reliance on MRI for certain quantitative tasks.

Across organ systems, the reviews highlight where these capabilities matter most operationally. Oncology-focused pictorial and narrative reviews map PCD-CT’s material-specific imaging strengths (low-keV virtual monoenergetic imaging, iodine mapping, and decomposition) to actionable goals like tumor conspicuity and local extent assessment. Complementing this, an oncology contrast review underscores that even with advanced hardware, diagnostic performance depends heavily on practical contrast-phase selection and timing—reinforcing that “what you scan” and “when you scan after contrast” are as important as detector technology. Finally, cardiothoracic evidence synthesis and a cardiac motion-correction study point to two pragmatic levers for clinical adoption: improved spatial/contrast resolution and intrinsic spectral information, and reconstruction strategies that reduce motion artifacts to better visualize native and prosthetic heart valves.

---

Spectral/Material Decomposition & Iodine Quantification

Evaluation of iodine detection and quantification limits in photon-counting CT-a phantom study.

This phantom study evaluated iodine detection threshold, quantification precision, and measurement linearity across photon-counting CT (PCCT) and dual-energy CT (DECT) systems using head and abdominal protocols with iodine test tubes spanning 0.0–2.0 mg/mL. The key finding was that iodine detection and quantification performance could be characterized in a laboratory-science framework (detection/quantification limits and linearity) for both PCCT and DECT, enabling direct comparison of how accurately each system measures iodine concentration in CT iodine maps. These results are clinically significant because they define the reliability limits of CT-derived iodine maps that underpin contrast-enhancement–based decision-making in practice.

Titternes R, Poludniowski G, Brismar TB et al. · European radiology experimental · (2026) · View on PubMed ↗

---

Motion Correction & Image Quality in Cardiac CT

Improved Visualization of Heart Valves With 4D-CT Using a Novel Motion Correction Algorithm.

In a retrospective single-center study of 57 patients (median age 71 years) undergoing photon-counting detector CT (PCD-CT), investigators tested a novel reconstruction-based motion correction algorithm to improve visualization of native and prosthetic heart valves. The key finding was that the motion-correction reconstruction reduced motion artifacts and improved image quality compared with standard reconstructions, particularly relevant for phases of rapid cardiac motion. This is scientifically and clinically significant because better valve visualization can improve assessment of valvular movement and pathology on cardiac CT.

Zedler D, Demmert TT, Ritter A et al. · Investigative radiology · (2026) · View on PubMed ↗

---

Oncology Imaging Applications of Photon-Counting CT

Practical applications of photon-counting CT in oncology: an organ-based pictorial review.

This organ-based pictorial review summarized practical oncology applications of photon-counting CT (PCD-CT), contrasting its spectral/material-specific capabilities with conventional energy-integrating detector CT (EID-CT) dual-energy CT (DECT) approaches. The key finding was that PCD-CT can extend or improve material-specific imaging (e.g., low-keV virtual monoenergetic imaging, iodine mapping, and material decomposition) to enhance tumor conspicuity, delineate local extent, and support tissue characterization while potentially mitigating DECT limitations such as low-keV noise and workflow complexity. This review is significant for guiding clinical adoption of PCD-CT in oncology by mapping where spectral CT benefits translate into actionable imaging tasks.

Kawasaki Y, Yokoyama K, Hada H et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Contrast Agent Protocols & Phase Optimization in Oncology

[Contrast agent strategies in elective oncological imaging].

This narrative review discussed contrast agent strategies for elective oncological imaging, focusing on how intravenous contrast timing and selection of contrast phases affect detection and characterization of intraparenchymal lesions across CT and MRI. The key finding was that, beyond general indications for contrast use, practical protocol implementation—especially choosing the optimal contrast phase—critically influences lesion conspicuity and diagnostic performance in routine oncology workflows. This is clinically significant because it provides a framework for aligning guideline-based imaging frequency and modality with real-world contrast-phase decisions.

Gerwing M, Eisenblätter M · Radiologie (Heidelberg, Germany) · (2026) · View on PubMed ↗

---

Cardiothoracic Imaging Evidence & Protocol Implications

Photon-Counting Detector CT in Cardiothoracic Imaging: AJR Expert Panel Narrative Review.

This AJR Expert Panel narrative review synthesized evidence on photon-counting detector CT (PCD-CT) for cardiothoracic imaging, comparing its spectral and resolution advantages with conventional energy-integrating detector CT (EID-CT). The key finding was that PCD-CT offers improved spatial/contrast resolution and intrinsic spectral information, with potential benefits including reduced radiation dose and reduced contrast media volume for cardiothoracic indications. This is significant because it consolidates the current clinical evidence base to support how PCD-CT may change cardiothoracic imaging protocols and patient management.

Milos RI, Siegel MJ, Bluemke DA et al. · AJR. American journal of roentgenology · (2026) · 1 citations · View on PubMed ↗

---

CT-Based Quantification of Tissue Composition (Marrow Fat/PDFF Correlates)

Quantitative assessment of vertebral bone marrow adipose tissue using photon-counting CT compared with MRI.

This prospective study compared photon-counting CT (PCCT)–derived quantitative measures of vertebral bone marrow adipose tissue (BMAT) with MRI proton density fat fraction (PDFF) as the reference standard in adult participants with low back pain. The key finding was that PCCT parameters—including virtual non-calcium (VNCa) CT values, VNCa CT fat fraction (CTFF), and standardized 70 keV CT values—showed measurable correlation and agreement with MRI PDFF at vertebral and subject levels. This is clinically significant because it supports the feasibility of noninvasive, CT-based quantification of BMAT that could complement or reduce reliance on MRI for assessing marrow fat composition.

Shu D, Wang J, Liang D et al. · European journal of radiology · (2026) · View on PubMed ↗

---

---

Generated automatically on October 12, 2026. Covers PubMed articles published October 05, 2026 – October 12, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.